Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,879 | -3,288 | -12,600 | -10,144 | -7,172 |
| Depreciation Amortization | 11 | 5 | 22 | 16 | 11 |
| Accounts payable and accrued liabilities | 222 | 33 | -647 | -716 | -162 |
| Other Working Capital | 639 | 432 | -929 | -261 | 63 |
| Other Operating Activity | -29 | 61 | 1,259 | 1,171 | 498 |
| Operating Cash Flow | $-6,036 | $-2,757 | $-12,894 | $-9,933 | $-6,762 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-15 | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 35,599 | 35,099 | 5,048 | 834 | 459 |
| Other Financing Activity | -2,913 | -475 | -408 | -36 | -18 |
| Financing Cash Flow | $32,686 | $34,624 | $4,640 | $799 | $441 |
| Exchange Rate Effect | -1 | 0 | 5 | 3 | 4 |
| Beginning Cash Position | 14,641 | 14,641 | 22,890 | 22,890 | 22,890 |
| End Cash Position | 41,275 | 46,508 | 14,641 | 13,759 | 16,573 |
| Net Cash Flow | $26,635 | $31,867 | $-8,254 | $-9,131 | $-6,317 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,036 | -2,757 | -12,894 | -9,933 | -6,762 |
| Capital Expenditure | -15 | N/A | N/A | N/A | 0 |
| Free Cash Flow | -6,051 | -2,757 | -12,894 | -9,933 | -6,762 |